Evidence-based medicine and sleep apnea

Area of Science:

• Sleep Medicine
• Cardiovascular Health
• Respiratory Medicine

Background:

• Obstructive sleep apnea (OSA) is increasingly linked to systemic blood pressure and reduced quality of life.
• Evidence connecting OSA to broader cardiovascular morbidity and mortality requires further investigation.
• A critical review of current literature on OSA's health impact, diagnosis, and treatment is warranted.

Purpose of the Study:

• To review the existing literature on the health impact, diagnosis, and treatment of obstructive sleep apnea (OSA).
• To establish a framework for evaluating the quality of evidence in OSA research.
• To highlight the utility of portable monitoring devices and continuous positive airway pressure (CPAP) therapy.

Main Methods:

• Systematic review of current literature on obstructive sleep apnea (OSA).
• Evaluation of diagnostic tools including clinical prediction rules and unattended portable monitoring devices (e.g., digital oximeters).
• Analysis of evidence from randomized, placebo-controlled trials for OSA treatments like CPAP and mandibular advancement.

Main Results:

• Portable monitoring devices and clinical prediction rules demonstrate clinical utility in diagnosing OSA, potentially reducing the need for polysomnography.
• Continuous positive airway pressure (CPAP) therapy significantly improves quality of life, driving performance, blood pressure, and sleepiness in OSA patients.
• Evidence supporting mandibular advancement is less robust, and surgical interventions for OSA lack strong supporting data.

Conclusions:

• Diagnostic approaches for OSA are becoming more accessible and effective with portable monitoring.
• CPAP is a well-supported treatment for OSA with clear benefits for multiple health parameters.
• Further large-scale, long-term randomized controlled trials are necessary to fully ascertain the benefits of various OSA treatment modalities.